A CLINICAL TRIAL OF NALIDIXIC ACID (NEGRAM) IN URINARY INFECTIONS.
D000293:Adolescent; D000890:Anti-Infective Agents; D035843:Biomedical Research; D002648:Child; D004358:Drug Therapy; D004927:Escherichia coli Infections; D005853:Geriatrics; D009268:Nalidixic Acid; D009287:Naphthyridines; D011512:Proteus Infections; D011552:Pseudomonas Infections; D013203:Staphylococcal Infections; D014116:Toxicology; D014552:Urinary Tract Infections
D000890:Anti-Infective Agents; D009287:Naphthyridines; D009268:Nalidixic Acid
ADOLESCENCE; ANTI-INFECTIVE AGENTS; CHILD; CLINICAL RESEARCH; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; GERIATRICS; NALIDIXIC ACID; NAPHTHYRIDINES; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TOXICOLOGIC REPORT; URINARY TRACT INFECTIONS